Press ReleasesNovember 12, 2024Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid GrowthRead
Press ReleasesSeptember 5, 2024Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland CapitalRead
Press ReleasesJuly 26, 2024BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen GenotypingRead
Press ReleasesJune 21, 2024Leading Molecular Diagnostics Company BillionToOne Raises $130 Million in Oversubscribed Series D Funding Over $1B+ ValuationRead
Press ReleasesApril 17, 2024BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TESTRead